The
AIDS virus, HIV-1, produces Vif (virion infectivity factor) protein during the
late stages of infection. Vif seems to inhibit an innate antiviral activity expressed
in human T lymphocytes. Sheehy et al. have now identified a human gene,
CEM15, as the cellular target of Vif. Molecules that render the T-cell enzyme
'Vif-proof', or interfere with Vif's inhibitory function, could make ideal candidates
for new anti-HIV drugs. On the cover, immunofluorescent staining of an HIV-1-infected
human macrophage with Vif in green.
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein ANN M. SHEEHY, NATHAN C. GADDIS, JONATHAN D. CHOI & MICHAEL H. MALIM Nature418, 646650 (2002); doi:10.1038/nature00939
| First Paragraph | Full Text (HTML / PDF) |
HIV: A tough viral nut to crack ROGER J. POMERANTZ
HIV cannot multiply in certain human cells unless it expresses a protein called Vif, the function of which has finally been revealed. It seems that it overcomes a human protein that would otherwise block viral replication. Nature418, 594595 (2002); doi:10.1038/418594a
| Full Text (HTML / PDF) |